{"id":2099,"date":"2026-06-07T11:00:00","date_gmt":"2026-06-07T14:00:00","guid":{"rendered":"https:\/\/sevenresiduosaude.com.br\/blog\/?p=2099"},"modified":"2026-06-07T11:00:00","modified_gmt":"2026-06-07T14:00:00","slug":"pgrss-cancer-testicular-oncologica-orquiectomia-rplnd-bep-hcg-afp-seminoma-nao-seminoma","status":"publish","type":"post","link":"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-cancer-testicular-oncologica-orquiectomia-rplnd-bep-hcg-afp-seminoma-nao-seminoma\/","title":{"rendered":"PGRSS testicular: orquiectomia, RPLND, BEP"},"content":{"rendered":"<p>A regula\u00e7\u00e3o brasileira de RSS \u00e9 frequentemente desafiada por gestores de centros de oncologia testicular. Em 2026, h\u00e1 uma demanda crescente de hospitais com unidade testicular oncol\u00f3gica \u2014 <strong>c\u00e2ncer testicular germinal<\/strong> com seminoma puro 50% (cl\u00e1ssico + espermatoc\u00edtico) + n\u00e3o-seminoma 50% (carcinoma embrion\u00e1rio + tumor saco vitel\u00ednico + coriocarcinoma + teratoma + misto), <strong>orquiectomia radical inguinal<\/strong> com cord\u00e3o esperm\u00e1tico at\u00e9 anel inguinal interno + clamp + retirada radical, <strong>estadiamento cl\u00ednico<\/strong> com marcadores tumorais HCG (\u03b2-hCG) + AFP alfa-fetoprote\u00edna + LDH desidrogenase l\u00e1ctica + CT abdome+t\u00f3rax + TC PET-CT, <strong>BEP regimen<\/strong> bleomicina + etoposide + cisplatina \u00d7 3-4 ciclos para non-seminoma + RT 25-30Gy para seminoma est\u00e1gio I-II Lista C5, <strong>RPLND retroperitoneal lymph node dissection<\/strong> prim\u00e1ria para non-seminoma I-II + post-chemotherapy desbridamento de massa residual, <strong>VeIP regimen salvage<\/strong> vinblastina + ifosfamida + cisplatina segunda linha + paclitaxel + gemcitabina, <strong>HDCT high-dose chemotherapy + aut\u00f3logo TMO<\/strong> para refrat\u00e1rio com carboplatina+etoposide, <strong>pr\u00f3tese testicular<\/strong> Mentor Saline \/ Coloplast Torosa \/ Promedon Tabuk \/ VPI Andrology R$ 4-12k p\u00f3s-orquiectomia bilateral ou cosm\u00e9tica, <strong>criopreserva\u00e7\u00e3o espermatozoide pr\u00e9-quimio<\/strong> com banco de s\u00eamen + 18-24 meses reten\u00e7\u00e3o, <strong>enuclea\u00e7\u00e3o testicular<\/strong> TSS testis-sparing surgery para tumor pequeno T1a benign possible. A consequ\u00eancia \u00e9 a urg\u00eancia de <strong>PGRSS dedicado para testicular oncol\u00f3gico<\/strong> \u2014 captura de <strong>pe\u00e7a operat\u00f3ria orquiectomia<\/strong> com test\u00edculo + cord\u00e3o esperm\u00e1tico at\u00e9 anel inguinal interno (test\u00edculo 15-30g + cord\u00e3o 5-15cm), <strong>BEP regimen Lista C5<\/strong> bleomicina 30 IU + etoposide 100mg\/m\u00b2 + cisplatina 20mg\/m\u00b2 \u00d7 3-4 ciclos R$ 8-15k\/ciclo + bolsa infus\u00e3o CADD-Solis + port-a-cath PowerPort Bard, <strong>pr\u00f3tese testicular<\/strong> Mentor \/ Coloplast \/ Promedon \/ VPI R$ 4-12k implante permanente + livro RBI 10y + tecnovigil\u00e2ncia, <strong>kit marcador tumoral<\/strong> \u03b2-hCG + AFP + LDH ELISA + ECLIA Roche Cobas R$ 50-200\/exame \u00d7 4-6 dosagens\/ciclo, <strong>carboplatina + etoposide HDCT<\/strong> + filgrastim G-CSF + criopreserva\u00e7\u00e3o CTH apheresis + bolsa CryoStor + N2 -196\u00b0C tank, <strong>bolsa de s\u00eamen criopreservada<\/strong> banco com Cryotop + nitrog\u00eanio + livro RBI 18-24 meses, <strong>kit RPLND retroperitoneal<\/strong> com cartucho EndoGIA Tri-Staple Medtronic + Harmonic ACE + LigaSure + dreno aspirativo Hemovac, <strong>paclitaxel + gemcitabina + ifosfamida<\/strong> salvage Lista C5 com cofre. A realidade \u00e9 que testicular onc produz RSS de alt\u00edssima complexidade. <strong>PGRSS de testicular onc \u00e9 cadeia integrada<\/strong> \u2014 come\u00e7a no <strong>diagn\u00f3stico<\/strong> (US escrotal + marcador tumoral + biopsia + IHC), passa pelo <strong>tratamento<\/strong> (orquiectomia + BEP + RPLND + RT) e termina na <strong>fertilidade + sobrevida<\/strong> (criopreserva\u00e7\u00e3o s\u00eamen + followup 5-10y + segundo tumor). O conjunto soma <strong>R$ 22.000-48.000\/m\u00eas<\/strong> que muitos gestores subestimam.<\/p>\n<p>Para o gestor que opera ou planeja unidade testicular onc, \u00e9 fundamental considerar a complexidade desde o in\u00edcio.<\/p>\n<h2>Os procedimentos testicular oncol\u00f3gico e os RSS espec\u00edficos<\/h2>\n<p>Em uma opera\u00e7\u00e3o de qualquer porte, a cadeia gera RSS espec\u00edficos.<\/p>\n<table>\n<thead>\n<tr>\n<th>Procedimento<\/th>\n<th>Insumo cr\u00edtico<\/th>\n<th>Anatomopatol\u00f3gico<\/th>\n<th>Risco RSS<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Orquiectomia inguinal<\/td>\n<td>Bisturi + clamp<\/td>\n<td>Test\u00edculo+cord\u00e3o 15-30g<\/td>\n<td>A4 + RBI tecnovig<\/td>\n<\/tr>\n<tr>\n<td>BEP Lista C5<\/td>\n<td>Bolsa infus\u00e3o+CADD<\/td>\n<td>Bleo+VP-16+cisplatina C5<\/td>\n<td>A4 + B Lista C5<\/td>\n<\/tr>\n<tr>\n<td>RPLND retroperitoneal<\/td>\n<td>EndoGIA+Harmonic<\/td>\n<td>Linfonodos para-aorto<\/td>\n<td>A4 + RBI<\/td>\n<\/tr>\n<tr>\n<td>Pr\u00f3tese testicular<\/td>\n<td>Mentor\/Coloplast R$ 4-12k<\/td>\n<td>N\u00e3o-aplic\u00e1vel<\/td>\n<td>A4 + RBI permanente<\/td>\n<\/tr>\n<tr>\n<td>Criopreserva\u00e7\u00e3o s\u00eamen<\/td>\n<td>Cryotop + N2 -196\u00b0C<\/td>\n<td>Bolsa de s\u00eamen<\/td>\n<td>A4 + RBI 18-24m<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A soma t\u00edpica \u00e9 entre <strong>R$ 22.000-48.000\/m\u00eas<\/strong> em PGRSS dedicado de testicular onc vs <strong>R$ 8.000-18.000<\/strong> em PGRSS gen\u00e9rico subdimensionado.<\/p>\n<h2>A orquiectomia + pr\u00f3tese testicular: o procedimento de alt\u00edssima precis\u00e3o<\/h2>\n<p>A primeira camada do desafio \u00e9 a orquiectomia. Padr\u00e3o setorial inclui (a) <strong>acesso inguinal<\/strong> com retirada de test\u00edculo + cord\u00e3o esperm\u00e1tico at\u00e9 anel inguinal interno + clamp pr\u00e9vio \u00e0 manipula\u00e7\u00e3o tumor; (b) <strong>biopsia transcord\u00e3o evitada<\/strong> para evitar implanta\u00e7\u00e3o local; (c) <strong>pr\u00f3tese testicular implant\u00e1vel<\/strong> Mentor Saline \/ Coloplast Torosa \/ Promedon Tabuk \/ VPI Andrology R$ 4-12k cosm\u00e9tica opcional p\u00f3s-op; (d) <strong>livro RBI pr\u00f3tese testicular<\/strong> com reten\u00e7\u00e3o 10 anos + tecnovigil\u00e2ncia; (e) <strong>criopreserva\u00e7\u00e3o s\u00eamen pr\u00e9-op<\/strong> banco de s\u00eamen com Cryotop + N2 -196\u00b0C + livro RBI 18-24 meses reten\u00e7\u00e3o m\u00ednima.<\/p>\n<p>Hospital com 80-250 orquiectomias\/ano + 30-100 pr\u00f3teses \u00d7 R$ 8k m\u00e9dio + 50-150 criopreserva\u00e7\u00f5es = R$ 240-1.4M\/ano em testicular cirurgia + livro RBI. Como discutimos no post sobre <a href=\"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-urologia-oncologica-prostatectomia-radical-nefrectomia-robotica-brachy-cistectomia-bca\/\">PGRSS de uro onc<\/a>, tecnovigil\u00e2ncia \u00e9 estruturante.<\/p>\n<h2>O BEP regimen + RPLND + VeIP salvage: o est\u00e1gio de chemo intensivo<\/h2>\n<p>A segunda camada \u00e9 o BEP. Padr\u00e3o setorial inclui (a) <strong>BEP regimen<\/strong> bleomicina 30 IU dias 2+9+16 + etoposide 100mg\/m\u00b2 dias 1-5 + cisplatina 20mg\/m\u00b2 dias 1-5 cada 21 dias \u00d7 3-4 ciclos Lista C5 R$ 8-15k\/ciclo; (b) <strong>EP regimen<\/strong> etoposide + cisplatina alternativa para baixo risco; (c) <strong>RPLND retroperitoneal lymph node dissection<\/strong> prim\u00e1ria para non-seminoma I-II + post-chemotherapy para massa residual >1cm com cartucho EndoGIA + Harmonic; (d) <strong>VeIP salvage<\/strong> vinblastina + ifosfamida + cisplatina segunda linha; (e) <strong>paclitaxel + gemcitabina + oxaliplatina<\/strong> terceira linha.<\/p>\n<p>Hospital com 80-250 BEPs\/ano \u00d7 3-4 ciclos \u00d7 R$ 12k = R$ 2.9-12M\/ano em BEP + cofre Lista C5 + cadeia fria.<\/p>\n<h2>O HDCT + aut\u00f3logo TMO + criopreserva\u00e7\u00e3o CTH: o est\u00e1gio refrat\u00e1rio<\/h2>\n<p>A terceira camada \u00e9 o refrat\u00e1rio. Padr\u00e3o setorial inclui (a) <strong>HDCT high-dose chemotherapy<\/strong> carboplatina AUC 7-8 + etoposide 400mg\/m\u00b2 \u00d7 3 ciclos para refrat\u00e1rio\/reca\u00edda tardia; (b) <strong>aut\u00f3logo TMO<\/strong> com mobiliza\u00e7\u00e3o CTH G-CSF filgrastim + apheresis Spectra Optia + criopreserva\u00e7\u00e3o DMSO 10% + bag CryoStor; (c) <strong>filgrastim G-CSF<\/strong> + plerixafor mobiliza\u00e7\u00e3o; (d) <strong>monitoriza\u00e7\u00e3o \u03b2-hCG + AFP + LDH<\/strong> + RM + PET-CT; (e) <strong>livro RBI HDCT + aut\u00f3logo<\/strong> com REDOME + reten\u00e7\u00e3o 10 anos.<\/p>\n<p>Hospital com 5-20 HDCTs\/ano \u00d7 R$ 100-200k tratamento = R$ 500k-4M\/ano em HDCT refrat\u00e1rio + aut\u00f3logo TMO.<\/p>\n<h2>Tr\u00eas perfis de PGRSS para testicular onc<\/h2>\n<p><strong>PGRSS gen\u00e9rico subdimensionado.<\/strong> Sem cobertura espec\u00edfica para BEP + pr\u00f3tese + criopreserva\u00e7\u00e3o. Custo mensal <strong>R$ 8.000-18.000<\/strong>, efic\u00e1cia limitada.<\/p>\n<p><strong>PGRSS dedicado intermedi\u00e1rio.<\/strong> Cobertura para orquiectomia + BEP, sem RPLND + HDCT + criopreserva\u00e7\u00e3o s\u00eamen. Custo mensal <strong>R$ 18.000-32.000<\/strong>, efic\u00e1cia 100-200%.<\/p>\n<p><strong>PGRSS dedicado completo testicular onc.<\/strong> Orquiectomia + BEP + RPLND + HDCT + pr\u00f3tese + criopreserva\u00e7\u00e3o + integra\u00e7\u00e3o com <a href=\"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-urologia-oncologica-prostatectomia-radical-nefrectomia-robotica-brachy-cistectomia-bca\/\">PGRSS de uro oncol\u00f3gica<\/a>. Custo mensal <strong>R$ 32.000-48.000<\/strong>, ROI 250-500%.<\/p>\n<h2>Os tr\u00eas erros que aparecem em PGRSS testicular onc subdimensionado<\/h2>\n<p>O primeiro \u00e9 o <strong>subdimensionamento de Lista C5 BEP + VeIP<\/strong>. Bleomicina+VP-16+cisplatina+vinblastina+ifosfamida com cofre + livro 344.<\/p>\n<p>O segundo \u00e9 a <strong>aus\u00eancia de RBI pr\u00f3tese testicular<\/strong>. Mentor\/Coloplast\/Promedon R$ 4-12k \u00e9 tecnovigil\u00e2ncia obrigat\u00f3ria + reten\u00e7\u00e3o 10 anos.<\/p>\n<p>O terceiro \u00e9 a <strong>descarte de criopreserva\u00e7\u00e3o s\u00eamen como Grupo D<\/strong>. Cryotop + N2 -196\u00b0C com livro RBI 18-24 meses + Lei 11.105 Biosseguran\u00e7a + Resolu\u00e7\u00e3o CFM 2.320.<\/p>\n<p>A regula\u00e7\u00e3o de PGRSS no Brasil est\u00e1 em fase de moderniza\u00e7\u00e3o t\u00e9cnica acelerada com testicular onc como prioridade. As institui\u00e7\u00f5es que estruturam PGRSS dedicado desde o in\u00edcio \u2014 alinhadas com <a href=\"https:\/\/sevenresiduosaude.com.br\/blog\/calendario-2026-compliance-rss-datas-fiscalizacao\/\">calend\u00e1rio 2026 de compliance<\/a> \u2014 atravessam o crescimento sem solavanco. Para gestores que precisam alinhar com gest\u00e3o paralela industrial, o <a href=\"https:\/\/sevenresiduos.com.br\/servicos\/\">portal Seven Res\u00edduos sobre servi\u00e7os completos<\/a> traz a perspectiva integrada. A <a href=\"https:\/\/portaldaurologia.org.br\/\">SBU Sociedade Brasileira de Urologia<\/a> \u00e9 refer\u00eancia t\u00e9cnica.<\/p>\n<p><strong><a href=\"https:\/\/sevenresiduosaude.com.br\/orcamento\/\">Solicite cota\u00e7\u00e3o PGRSS de testicular oncol\u00f3gico<\/a><\/strong> \u2014 cap\u00edtulo dedicado a orquiectomia inguinal + pr\u00f3tese Mentor\/Coloplast\/Promedon\/VPI, BEP bleomicina+etoposide+cisplatina + EP, RPLND retroperitoneal + EndoGIA, VeIP salvage + HDCT + aut\u00f3logo TMO, criopreserva\u00e7\u00e3o s\u00eamen + Cryotop + Resolu\u00e7\u00e3o CFM 2.320.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Testicular oncol\u00f3gica gera RSS espec\u00edfico \u2014 orquiectomia, RPLND, BEP, HCG, AFP. PGRSS dedicado.<\/p>\n","protected":false},"author":3,"featured_media":2098,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[2917,2915,2916,2914],"class_list":["post-2099","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance-legislacao","tag-bep","tag-orquiectomia","tag-rplnd","tag-testicular"],"_links":{"self":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/comments?post=2099"}],"version-history":[{"count":1,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2099\/revisions"}],"predecessor-version":[{"id":4275,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2099\/revisions\/4275"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media\/2098"}],"wp:attachment":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media?parent=2099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/categories?post=2099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/tags?post=2099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}